Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer
Clinical trial NCT06173726 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06173726
- Sponsor
- BioSyngen Pte Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-05
- Primary completion
- 2026-12-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.